Safety and Efficacy of YB-1113 in Treatment of POI
Clinical trial NCT05494723 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05494723
- Sponsor
- Bright Cell, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-09
- Primary completion
- 2028-01-09
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.